A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocolElizaveta Gribaleva, Carsten Flohr, David Prieto-Merino et al.|Skin Health and Disease|2025Cited by 1